INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,683,172 | -16.7% | 211,359 | +7.4% | 0.18% | -14.2% |
Q2 2023 | $8,026,320 | +14.3% | 196,820 | +4.5% | 0.20% | +7.9% |
Q1 2023 | $7,020,929 | +15.9% | 188,380 | +8.5% | 0.19% | +9.9% |
Q4 2022 | $6,058,858 | -32.7% | 173,656 | +1.0% | 0.17% | -38.4% |
Q3 2022 | $9,000,000 | +3.9% | 171,854 | +2.7% | 0.28% | +7.3% |
Q2 2022 | $8,661,000 | +40.4% | 167,326 | +97.0% | 0.26% | +53.8% |
Q1 2022 | $6,171,000 | -34.4% | 84,921 | +6.8% | 0.17% | -32.9% |
Q4 2021 | $9,405,000 | +58.5% | 79,543 | +79.8% | 0.25% | +43.2% |
Q3 2021 | $5,935,000 | +1645.6% | 44,245 | +2006.9% | 0.18% | +1660.0% |
Q2 2021 | $340,000 | -89.2% | 2,100 | -98.1% | 0.01% | -94.7% |
Q3 2018 | $3,155,000 | +6.9% | 110,239 | +2.2% | 0.19% | +5.6% |
Q2 2018 | $2,952,000 | +29.1% | 107,912 | -0.5% | 0.18% | +29.9% |
Q1 2018 | $2,287,000 | +17.5% | 108,425 | +7.1% | 0.14% | +20.2% |
Q4 2017 | $1,946,000 | – | 101,230 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |